Veracyte, Inc. (VCYT)

4d ago, source: Yahoo Finance

SOUTH SAN FRANCISCO, Calif., February 27, 2024--Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines.

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024

3d ago, source:

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024 ...

What Makes Veracyte (VCYT) a Lucrative Investment?

17d ago, source: InvestingChannel on MSN

Next Century Growth Investors, LLC, an investment Management Company, released its "Micro-Cap Strategy" fourth-quarter ...

Veracyte Finalizes C2i Genomics Acquisition Deal

2mon ago, source: TipRanks on MSN

Veracyte, Inc. completed its acquisition of C2i Genomics for $70.0 million with additional future performance-based payments ...

Veracyte: Q4 Earnings Snapshot

1mon ago, source: San Antonio Express-News

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Thursday reported a loss of $28.3 million in its fourth quarter. On a per-share basis, the South ...

Veracyte Inc (VCYT) Earnings Dates & Reports

1mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Veracyte, Inc. (12V.F)

1mon ago, source: Yahoo Finance

Veracyte ( NASDAQ:VCYT ) Full Year 2023 Results Key Financial Results Revenue: US$361.1m (up 22% from FY 2022). Net... Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript February 22, 2024 ...

FDMT 4D Molecular Therapeutics, Inc.

1d ago, source: Seeking Alpha

4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States.

Veracyte Inc VCYT

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024

4d ago, source: Morningstar

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024 Veracyte, Inc. (Nasdaq: VCYT), a leading cancer ...

What Makes Veracyte (VCYT) a Lucrative Investment?

17d ago, source: Insider Monkey

NCG Micro-Cap Strategy featured stocks like Veracyte, Inc. (NASDAQ:VCYT) in the Q4 2023 investor letter. Headquartered in South San Francisco, California, Veracyte, Inc. (NASDAQ:VCYT) is a ...

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024

3d ago, source: Stockhouse

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher Prostate and Decipher Bladder Genomic Classifiers will be presented at ...